NCT00984529已完成不适用
Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 500
- 试验地点
- 2
- 主要终点
- To evaluate clinical signs and symptoms of chronic heart failure (in terms of NYHA status, fluid retention and tiredness/fatigue) after at least 6 months of treatment with candesartan cilexetil
研究概览
简要总结
The purpose of this study is to determine whether treatment with candesartan cilexetil for at least 6 months in patients with chronic heart failure improves clinical signs and symptoms of chronic heart failure.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with diagnosed chronic heart failure
- •Patients treated for at least 6 months with candesartan cilexetil
- •Signed Informed consent
排除标准
- •Hypersensitivity to candesartan cilexetil
- •Pregnancy / lactation
- •Severe hepatic impairment
结局指标
主要结局
To evaluate clinical signs and symptoms of chronic heart failure (in terms of NYHA status, fluid retention and tiredness/fatigue) after at least 6 months of treatment with candesartan cilexetil
时间窗: 1 visit (after at least 6 months of treatment)
次要结局
- To evaluate ventricular function after at least 6 months of treatment with candesartan cilexetil(1 visit (after at least 6 months of treatment))
- To gain insight into usage of candesartan cilexetil in real life for chronic heart failure in Croatia(1 visit (after at least 6 months of treatment))
- To evaluate patient's compliance with prescribed treatment(1 visit (after at least 6 months of treatment))
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
DIabetic Retinopathy Candesartan TrialsType 2 DiabetesNCT00252694AstraZeneca4,717
已完成
3 期
High Doses of Candesartan Cilexetil on the Reduction of ProteinuriaProteinuriaNCT00242346AstraZeneca270
已完成
2 期
Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and PlaceboObesityHypertensionNCT00282178Umeå University26
已完成
3 期
Diabetic Retinopathy Candesartan TrialsType 1 DiabetesNCT00252733AstraZeneca5,238
已完成
3 期
TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention TrialHypertensionNCT00227318AstraZeneca1,000